Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.5160 per EA under NDC 67877072990. Its NADAC has been published 230 times since Feb 2, 2022.
Strength
225 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877072990
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214127On Market Since
6/11/2021
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 230 times since Feb 2, 2022, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5160 per EA |
|---|---|
| All-time high | $3.6016 (Feb 16, 2022) |
| All-time low | $0.4592 (Nov 20, 2024) |
| 52-week high | $0.6923 |
| 52-week low | $0.4955 |
| Median price | $0.7415 |
| Average price | $1.1214 |
| Largest weekly change | +54.1% (Feb 22, 2023) |
| Weeks tracked | 230 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.5160 per EA (NDC 67877072990), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 85.7%. It has been tracked across 230 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since Feb 2, 2022, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $3.6016 (Feb 16, 2022), with a median of $0.7415 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 225 MG TAB, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 67877072990) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification